Computer Simulations Are the New Frontier in COVID-19 Drug Trials
University of Waterloo | July 19, 2021
Models allow for virtual trials of drugs and vaccines, to test their efficacy against COVID-19
Drug Development
First Molecular Blueprint of Neuropeptide Receptor
Universität Leipzig | February 11, 2021
The blueprint will enable the development of tailor-made drugs to treat epilepsy or cardiovascular diseases
More Than 200 Genetic Factors Cause Heart Arrhythmias
Queen Mary University of London | May 25, 2020
Research results could one day lead to advanced screening methods to discern who is at greatest risk of developing disease
Hamilton and IMCS Jointly Develop affinityPure™ STAR Assay Ready Workstation to Aid Coronavirus Research
Hamilton Robotics | April 28, 2020
Robust workflow solution enables rapid, high throughput protein affinity purifications
Global COVID-19 Clinical Trial Tracker Launched by Cytel
Cytel | April 8, 2020
Live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic
Turbo Chip for Drug Development
Karlsruhe Institute of Technology | July 15, 2019
KIT scientists develop process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip
Drug Discovery: From Lab to Pharmacy
Lab Manager | November 7, 2018
The journey from lead discovery to final approval can be long and challenging